Analysis of psoriasis-relevant gene expression and exon usage alterations after silencing of SR-rich splicing regulators

Eszter Szlavicz, Peter Olah, Kornélia Szabo, Franco Pagani, Z. Bata-Csörgő, L. Kemény, M. Széll

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In our recent cDNA microarray experiment, three SR-rich splicing factors—SFRS18, PPIG and LUC7L3—were shown to exert altered responsiveness upon T-lymphokine stimulation of psoriatic non-involved and healthy epidermis samples. We have also demonstrated that double silencing LUC7L3 and SFRS18 efficiently decreased production of the psoriasis-associated EDA+ fibronectin isoform. These findings prompted the further investigation of signalling pathways affected by LUC7L3 and SFRS18. To detect gene expression and splicing pattern alterations upon double silencing of LUC7L3 and SFRS18 in an HPV-immortalised keratinocyte cell culture, paired-end RNA sequencing was carried out. Marked changes in exon usage were revealed, in contrast to the modest alterations detected in gene expression, providing a closer delineation of the potential targets of the examined splicing factors. The most prominent gene expression change was detected for IFI6, an interferon-inducible gene highly expressed in psoriasis. Interacting partners of IFI6 and certain psoriasis-associated transcripts also exhibited significantly increased expression upon silencing. In addition to elevated abundance of the EDA+ fibronectin interactor ITGA5, we confirmed decreased EDA domain inclusion, which agrees well with our prior experimental data. Furthermore, differential exon usage was established for the transcription element CREB1, along with HERC6 and CUL1, which are implicated in ubiquitination. Although immortalised keratinocytes express low levels of TINCR, a long non-coding RNA involved in terminal differentiation of keratinocytes, splicing alterations were successfully demonstrated for this RNA as well. We believe that the targeted investigation of mRNA maturation disturbances may help us gain deeper insight into the molecular pathogenesis of psoriasis.

Original languageEnglish
Pages (from-to)656-662
Number of pages7
JournalExperimental Dermatology
Volume27
Issue number6
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Psoriasis
Gene expression
Exons
Keratinocytes
Fibronectins
Gene Expression
Long Noncoding RNA
RNA
Lymphokines
Transcription
Microarrays
RNA Sequence Analysis
Cell culture
Interferons
Ubiquitination
Protein Isoforms
Complementary DNA
Genes
Oligonucleotide Array Sequence Analysis
Epidermis

Keywords

  • antiviral immunity
  • inflammation
  • mRNA maturation
  • non-coding RNAs
  • RNA-Sequencing

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology

Cite this

Analysis of psoriasis-relevant gene expression and exon usage alterations after silencing of SR-rich splicing regulators. / Szlavicz, Eszter; Olah, Peter; Szabo, Kornélia; Pagani, Franco; Bata-Csörgő, Z.; Kemény, L.; Széll, M.

In: Experimental Dermatology, Vol. 27, No. 6, 01.06.2018, p. 656-662.

Research output: Contribution to journalArticle

@article{a09d20775aba459ea70a5768c9cb3ab5,
title = "Analysis of psoriasis-relevant gene expression and exon usage alterations after silencing of SR-rich splicing regulators",
abstract = "In our recent cDNA microarray experiment, three SR-rich splicing factors—SFRS18, PPIG and LUC7L3—were shown to exert altered responsiveness upon T-lymphokine stimulation of psoriatic non-involved and healthy epidermis samples. We have also demonstrated that double silencing LUC7L3 and SFRS18 efficiently decreased production of the psoriasis-associated EDA+ fibronectin isoform. These findings prompted the further investigation of signalling pathways affected by LUC7L3 and SFRS18. To detect gene expression and splicing pattern alterations upon double silencing of LUC7L3 and SFRS18 in an HPV-immortalised keratinocyte cell culture, paired-end RNA sequencing was carried out. Marked changes in exon usage were revealed, in contrast to the modest alterations detected in gene expression, providing a closer delineation of the potential targets of the examined splicing factors. The most prominent gene expression change was detected for IFI6, an interferon-inducible gene highly expressed in psoriasis. Interacting partners of IFI6 and certain psoriasis-associated transcripts also exhibited significantly increased expression upon silencing. In addition to elevated abundance of the EDA+ fibronectin interactor ITGA5, we confirmed decreased EDA domain inclusion, which agrees well with our prior experimental data. Furthermore, differential exon usage was established for the transcription element CREB1, along with HERC6 and CUL1, which are implicated in ubiquitination. Although immortalised keratinocytes express low levels of TINCR, a long non-coding RNA involved in terminal differentiation of keratinocytes, splicing alterations were successfully demonstrated for this RNA as well. We believe that the targeted investigation of mRNA maturation disturbances may help us gain deeper insight into the molecular pathogenesis of psoriasis.",
keywords = "antiviral immunity, inflammation, mRNA maturation, non-coding RNAs, RNA-Sequencing",
author = "Eszter Szlavicz and Peter Olah and Korn{\'e}lia Szabo and Franco Pagani and Z. Bata-Cs{\"o}rgő and L. Kem{\'e}ny and M. Sz{\'e}ll",
year = "2018",
month = "6",
day = "1",
doi = "10.1111/exd.13530",
language = "English",
volume = "27",
pages = "656--662",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Analysis of psoriasis-relevant gene expression and exon usage alterations after silencing of SR-rich splicing regulators

AU - Szlavicz, Eszter

AU - Olah, Peter

AU - Szabo, Kornélia

AU - Pagani, Franco

AU - Bata-Csörgő, Z.

AU - Kemény, L.

AU - Széll, M.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - In our recent cDNA microarray experiment, three SR-rich splicing factors—SFRS18, PPIG and LUC7L3—were shown to exert altered responsiveness upon T-lymphokine stimulation of psoriatic non-involved and healthy epidermis samples. We have also demonstrated that double silencing LUC7L3 and SFRS18 efficiently decreased production of the psoriasis-associated EDA+ fibronectin isoform. These findings prompted the further investigation of signalling pathways affected by LUC7L3 and SFRS18. To detect gene expression and splicing pattern alterations upon double silencing of LUC7L3 and SFRS18 in an HPV-immortalised keratinocyte cell culture, paired-end RNA sequencing was carried out. Marked changes in exon usage were revealed, in contrast to the modest alterations detected in gene expression, providing a closer delineation of the potential targets of the examined splicing factors. The most prominent gene expression change was detected for IFI6, an interferon-inducible gene highly expressed in psoriasis. Interacting partners of IFI6 and certain psoriasis-associated transcripts also exhibited significantly increased expression upon silencing. In addition to elevated abundance of the EDA+ fibronectin interactor ITGA5, we confirmed decreased EDA domain inclusion, which agrees well with our prior experimental data. Furthermore, differential exon usage was established for the transcription element CREB1, along with HERC6 and CUL1, which are implicated in ubiquitination. Although immortalised keratinocytes express low levels of TINCR, a long non-coding RNA involved in terminal differentiation of keratinocytes, splicing alterations were successfully demonstrated for this RNA as well. We believe that the targeted investigation of mRNA maturation disturbances may help us gain deeper insight into the molecular pathogenesis of psoriasis.

AB - In our recent cDNA microarray experiment, three SR-rich splicing factors—SFRS18, PPIG and LUC7L3—were shown to exert altered responsiveness upon T-lymphokine stimulation of psoriatic non-involved and healthy epidermis samples. We have also demonstrated that double silencing LUC7L3 and SFRS18 efficiently decreased production of the psoriasis-associated EDA+ fibronectin isoform. These findings prompted the further investigation of signalling pathways affected by LUC7L3 and SFRS18. To detect gene expression and splicing pattern alterations upon double silencing of LUC7L3 and SFRS18 in an HPV-immortalised keratinocyte cell culture, paired-end RNA sequencing was carried out. Marked changes in exon usage were revealed, in contrast to the modest alterations detected in gene expression, providing a closer delineation of the potential targets of the examined splicing factors. The most prominent gene expression change was detected for IFI6, an interferon-inducible gene highly expressed in psoriasis. Interacting partners of IFI6 and certain psoriasis-associated transcripts also exhibited significantly increased expression upon silencing. In addition to elevated abundance of the EDA+ fibronectin interactor ITGA5, we confirmed decreased EDA domain inclusion, which agrees well with our prior experimental data. Furthermore, differential exon usage was established for the transcription element CREB1, along with HERC6 and CUL1, which are implicated in ubiquitination. Although immortalised keratinocytes express low levels of TINCR, a long non-coding RNA involved in terminal differentiation of keratinocytes, splicing alterations were successfully demonstrated for this RNA as well. We believe that the targeted investigation of mRNA maturation disturbances may help us gain deeper insight into the molecular pathogenesis of psoriasis.

KW - antiviral immunity

KW - inflammation

KW - mRNA maturation

KW - non-coding RNAs

KW - RNA-Sequencing

UR - http://www.scopus.com/inward/record.url?scp=85050220519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050220519&partnerID=8YFLogxK

U2 - 10.1111/exd.13530

DO - 10.1111/exd.13530

M3 - Article

VL - 27

SP - 656

EP - 662

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 6

ER -